Table 2.

Clinical Characteristics Among Rotavirus-positive Diarrhea With Enteric Coinfections (763 Episodes)

PathogenDiarrhea ≥5 Days
(n = 443 [62.9%])
Maximum Vomiting Episodes per Day
(0: n = 29 [4.1%]; 1: n = 54 [7.7%]; 2–4: n = 446 [63.4%]; ≥5: n = 175 [24.9%])
Dehydration, Any
(n = 366 [52.0%])
Hospitalization
(n = 444 [63.1%])
aOR(95% CI)aOR(95% CI)aOR(95% CI)aOR(95% CI)
Individual pathogena
 Adenovirus 40/411.61(.41–6.27)1.47(.41–5.24)1.18(.32–4.44)1.59(.42–5.98)
Shigella/EIEC2.88(.96–8.65)0.53(.20–1.46)1.80(.53–6.03)1.32(.42–4.21)
 Norovirus GII2.10(.39–11.29)0.50(.13–1.88)0.77(.10–5.72)0.40(.05–3.16)
Cryptosporidium1.82(.09–38.50)0.80(.04–17.07)6.55(.42–101.41)8.24(.46–148.18)
 Sapovirus5.19(.81–33.32)0.25(.04–1.56)1.61(.20–13.03)1.14(.16–8.18)
 ST-ETEC2.21(.67–7.35)1.01(.26–3.90)1.79(.44–7.34)1.31(.34–5.10)
Pathogen categorya
 Bacteriab2.01(1.07–3.76)0.95(.51–1.76)1.43(.68–3.02)0.97(.46–2.01)
 Virus (nonrotavirus)c2.05(.89–4.68)0.62(.32–1.19)1.27(.51–3.18)1.06(.43–2.57)
 Protozoad1.16(.08–15.82)2.77(.13–60.54)3.51(.33–36.71)15.39(1.41–167.81)
PathogenDiarrhea ≥5 Days
(n = 443 [62.9%])
Maximum Vomiting Episodes per Day
(0: n = 29 [4.1%]; 1: n = 54 [7.7%]; 2–4: n = 446 [63.4%]; ≥5: n = 175 [24.9%])
Dehydration, Any
(n = 366 [52.0%])
Hospitalization
(n = 444 [63.1%])
aOR(95% CI)aOR(95% CI)aOR(95% CI)aOR(95% CI)
Individual pathogena
 Adenovirus 40/411.61(.41–6.27)1.47(.41–5.24)1.18(.32–4.44)1.59(.42–5.98)
Shigella/EIEC2.88(.96–8.65)0.53(.20–1.46)1.80(.53–6.03)1.32(.42–4.21)
 Norovirus GII2.10(.39–11.29)0.50(.13–1.88)0.77(.10–5.72)0.40(.05–3.16)
Cryptosporidium1.82(.09–38.50)0.80(.04–17.07)6.55(.42–101.41)8.24(.46–148.18)
 Sapovirus5.19(.81–33.32)0.25(.04–1.56)1.61(.20–13.03)1.14(.16–8.18)
 ST-ETEC2.21(.67–7.35)1.01(.26–3.90)1.79(.44–7.34)1.31(.34–5.10)
Pathogen categorya
 Bacteriab2.01(1.07–3.76)0.95(.51–1.76)1.43(.68–3.02)0.97(.46–2.01)
 Virus (nonrotavirus)c2.05(.89–4.68)0.62(.32–1.19)1.27(.51–3.18)1.06(.43–2.57)
 Protozoad1.16(.08–15.82)2.77(.13–60.54)3.51(.33–36.71)15.39(1.41–167.81)

The aORs and 95% CIs for each clinical characteristic were estimated from multiple logistic or ordinal logistic (for vomiting episodes) regression models, with age, study site, treatment arm (RV or placebo), and pathogen or pathogen categories as predictors.

Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; EIEC, enteroinvasive Escherichia coli; ST-ETEC, stable toxin enterotoxigenic Escherichia coli.

aRotavirus detection by enzyme immunoassay was a binary predictor, while other pathogens and pathogen categories were modeled as continuous attributable fraction (AF) values.

bSum of AFs for Shigella/EIEC, Vibrio cholerae, ST-ETEC, Campylobacter jejuni/coli, typical enteropathogenic Escherichia coli, Aeromonas, and Salmonella.

cSum of AFs for adenovirus 40/41, norovirus GII, sapovirus, and astrovirus.

dSum of AFs for Cryptosporidium and Entamoeba histolytica.

Table 2.

Clinical Characteristics Among Rotavirus-positive Diarrhea With Enteric Coinfections (763 Episodes)

PathogenDiarrhea ≥5 Days
(n = 443 [62.9%])
Maximum Vomiting Episodes per Day
(0: n = 29 [4.1%]; 1: n = 54 [7.7%]; 2–4: n = 446 [63.4%]; ≥5: n = 175 [24.9%])
Dehydration, Any
(n = 366 [52.0%])
Hospitalization
(n = 444 [63.1%])
aOR(95% CI)aOR(95% CI)aOR(95% CI)aOR(95% CI)
Individual pathogena
 Adenovirus 40/411.61(.41–6.27)1.47(.41–5.24)1.18(.32–4.44)1.59(.42–5.98)
Shigella/EIEC2.88(.96–8.65)0.53(.20–1.46)1.80(.53–6.03)1.32(.42–4.21)
 Norovirus GII2.10(.39–11.29)0.50(.13–1.88)0.77(.10–5.72)0.40(.05–3.16)
Cryptosporidium1.82(.09–38.50)0.80(.04–17.07)6.55(.42–101.41)8.24(.46–148.18)
 Sapovirus5.19(.81–33.32)0.25(.04–1.56)1.61(.20–13.03)1.14(.16–8.18)
 ST-ETEC2.21(.67–7.35)1.01(.26–3.90)1.79(.44–7.34)1.31(.34–5.10)
Pathogen categorya
 Bacteriab2.01(1.07–3.76)0.95(.51–1.76)1.43(.68–3.02)0.97(.46–2.01)
 Virus (nonrotavirus)c2.05(.89–4.68)0.62(.32–1.19)1.27(.51–3.18)1.06(.43–2.57)
 Protozoad1.16(.08–15.82)2.77(.13–60.54)3.51(.33–36.71)15.39(1.41–167.81)
PathogenDiarrhea ≥5 Days
(n = 443 [62.9%])
Maximum Vomiting Episodes per Day
(0: n = 29 [4.1%]; 1: n = 54 [7.7%]; 2–4: n = 446 [63.4%]; ≥5: n = 175 [24.9%])
Dehydration, Any
(n = 366 [52.0%])
Hospitalization
(n = 444 [63.1%])
aOR(95% CI)aOR(95% CI)aOR(95% CI)aOR(95% CI)
Individual pathogena
 Adenovirus 40/411.61(.41–6.27)1.47(.41–5.24)1.18(.32–4.44)1.59(.42–5.98)
Shigella/EIEC2.88(.96–8.65)0.53(.20–1.46)1.80(.53–6.03)1.32(.42–4.21)
 Norovirus GII2.10(.39–11.29)0.50(.13–1.88)0.77(.10–5.72)0.40(.05–3.16)
Cryptosporidium1.82(.09–38.50)0.80(.04–17.07)6.55(.42–101.41)8.24(.46–148.18)
 Sapovirus5.19(.81–33.32)0.25(.04–1.56)1.61(.20–13.03)1.14(.16–8.18)
 ST-ETEC2.21(.67–7.35)1.01(.26–3.90)1.79(.44–7.34)1.31(.34–5.10)
Pathogen categorya
 Bacteriab2.01(1.07–3.76)0.95(.51–1.76)1.43(.68–3.02)0.97(.46–2.01)
 Virus (nonrotavirus)c2.05(.89–4.68)0.62(.32–1.19)1.27(.51–3.18)1.06(.43–2.57)
 Protozoad1.16(.08–15.82)2.77(.13–60.54)3.51(.33–36.71)15.39(1.41–167.81)

The aORs and 95% CIs for each clinical characteristic were estimated from multiple logistic or ordinal logistic (for vomiting episodes) regression models, with age, study site, treatment arm (RV or placebo), and pathogen or pathogen categories as predictors.

Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; EIEC, enteroinvasive Escherichia coli; ST-ETEC, stable toxin enterotoxigenic Escherichia coli.

aRotavirus detection by enzyme immunoassay was a binary predictor, while other pathogens and pathogen categories were modeled as continuous attributable fraction (AF) values.

bSum of AFs for Shigella/EIEC, Vibrio cholerae, ST-ETEC, Campylobacter jejuni/coli, typical enteropathogenic Escherichia coli, Aeromonas, and Salmonella.

cSum of AFs for adenovirus 40/41, norovirus GII, sapovirus, and astrovirus.

dSum of AFs for Cryptosporidium and Entamoeba histolytica.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close